A genetically heterogenous inherited disorder characterized by abnormalities in the metabolism of lipids and proteins. Signs and symptoms usually appear early in life and vary from mild to life threat...
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation for methylmalonic acidemia is limited due to its rarity and the complexity of its genetic underpinnings. Because this condition affects a relatively small population, systematic clinical studies have been scarce. Additionally, the genetic basis is still being characterized, contributing to the challenges in fully understanding the clinical features and variations in presentation.
To navigate your care for methylmalonic acidemia, consider seeking a metabolic specialist or a geneticist with experience in inherited metabolic disorders. These professionals can provide tailored care and management strategies. You may also explore opportunities for participation in clinical trials, which can offer access to cutting-edge treatments. For additional resources, visit the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov, which can help connect you with genetic counseling services. While no specific patient organizations are currently identified, staying informed through clinical trials and specialist consultations is crucial.
There are currently several orphan drugs in development for methylmalonic acidemia, including 2,2-dimethylbutanoic acid, adeno-associated virus 9 methylmalonyl Co-A mutase (AAV9-MMUT), and others targeting the underlying metabolic pathways. Additionally, there are 10 active clinical trials investigating various aspects of the condition. For more information on these trials, you can visit ClinicalTrials.gov and search for 'methylmalonic acidemia'.
Actionable guidance for navigating care for methylmalonic acidemia
To navigate your care for methylmalonic acidemia, consider seeking a metabolic specialist or a geneticist with experience in inherited metabolic disorders. These professionals can provide tailored care and management strategies. You may also explore opportunities for participation in clinical trials, which can offer access to cutting-edge treatments. For additional resources, visit the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov, which can help connect you with genetic counseling services. While no specific patient organizations are currently identified, staying informed through clinical trials and specialist consultations is crucial.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 7 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.